{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:52:23Z","timestamp":1768715543389,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00284-023-03432-8","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T10:01:31Z","timestamp":1697796091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0203-7347","authenticated-orcid":false,"given":"Alireza","family":"Mohebbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-9303","authenticated-orcid":false,"given":"Majid","family":"Eterafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2328-327X","authenticated-orcid":false,"given":"Nasrin","family":"Fouladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-5083","authenticated-orcid":false,"given":"Majid","family":"Golizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-7158","authenticated-orcid":false,"given":"Reza","family":"Panahizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-7369","authenticated-orcid":false,"given":"Shahram","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimia","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-8923","authenticated-orcid":false,"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"issue":"5","key":"3432_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.molmed.2020.02.008","volume":"26","author":"J Sun","year":"2020","unstructured":"Sun J, He W-T, Wang L, Lai A, Ji X, Zhai X et al (2020) COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med 26(5):483\u2013495","journal-title":"Trends Mol Med"},{"issue":"3","key":"3432_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.34172\/aim.2021.37","volume":"24","author":"A Raoofi","year":"2021","unstructured":"Raoofi A, Takian A, Haghighi H, Rajizadeh A, Rezaei Z, Radmerikhi S et al (2021) COVID-19 and comparative health policy learning; the experience of 10 countries. Arch Iran Med 24(3):260\u2013272. https:\/\/doi.org\/10.34172\/aim.2021.37","journal-title":"Arch Iran Med"},{"issue":"9","key":"3432_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3906\/sag-2004-146","volume":"50","author":"HR G\u00fcner","year":"2020","unstructured":"G\u00fcner HR, Hasano\u011flu \u0130, Akta\u015f F (2020) COVID-19: prevention and control measures in community. Turk J Med Sci 50(9):571\u2013577. https:\/\/doi.org\/10.3906\/sag-2004-146","journal-title":"Turk J Med Sci"},{"issue":"10223","key":"3432_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395(10223):507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"The Lancet"},{"key":"3432_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.14.20065771","author":"AT Huang","year":"2020","unstructured":"Huang AT, Garcia-Carreras B, Hitchings MD, Yang B, Katzelnick LC, Rattigan SM et al (2020) A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. MedRxiv. https:\/\/doi.org\/10.1101\/2020.04.14.20065771","journal-title":"MedRxiv"},{"issue":"6","key":"3432_CR6","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s10900-021-00984-3","volume":"46","author":"N Biswas","year":"2021","unstructured":"Biswas N, Mustapha T, Khubchandani J, Price JH (2021) The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. J Community Health 46(6):1244\u20131251. https:\/\/doi.org\/10.1007\/s10900-021-00984-3","journal-title":"J Community Health"},{"issue":"8","key":"3432_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0264-410x(95)00211-i","volume":"14","author":"AD Murdin","year":"1996","unstructured":"Murdin AD, Barreto L, Plotkin S (1996) Inactivated poliovirus vaccine: past and present experience. Vaccine 14(8):735\u2013746. https:\/\/doi.org\/10.1016\/0264-410x(95)00211-i","journal-title":"Vaccine"},{"issue":"15","key":"3432_CR8","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","volume":"27","author":"C Vellozzi","year":"2009","unstructured":"Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P (2009) Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 27(15):2114\u20132120. https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.125","journal-title":"Vaccine"},{"issue":"1","key":"3432_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40902-021-00330-6","volume":"44","author":"B Houshmand","year":"2022","unstructured":"Houshmand B, Keyhan SO, Fallahi HR, Ramezanzade S, Sadeghi E, Yousefi P (2022) Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students\u2014which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV (Sinopharm)? Maxillofac Plast Reconstr Surg 44(1):1\u201311. https:\/\/doi.org\/10.1186\/s40902-021-00330-6","journal-title":"Maxillofac Plast Reconstr Surg"},{"issue":"43","key":"3432_CR10","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1016\/j.vaccine.2021.09.030","volume":"39","author":"MA Sahraian","year":"2021","unstructured":"Sahraian MA, Ghadiri F, Azimi A, Moghadasi AN (2021) Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV. Vaccine 39(43):6347\u20136350. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.030","journal-title":"Vaccine"},{"issue":"3","key":"3432_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","volume":"182","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W et al (2020) Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182(3):713-721.e9. https:\/\/doi.org\/10.1016\/j.cell.2020.06.008","journal-title":"Cell"},{"issue":"1","key":"3432_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF et al (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis 21(1):39\u201351. https:\/\/doi.org\/10.1016\/S1473-3099(20)30831-8","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"3432_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2020.15543","volume":"324","author":"S Xia","year":"2020","unstructured":"Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z et al (2020) Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA 324(10):951\u2013960. https:\/\/doi.org\/10.1001\/jama.2020.15543","journal-title":"JAMA"},{"key":"3432_CR14","unstructured":"https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2021\/april\/2_sage29apr2021_critical-evidence_sinopharm.pdf. Accessed Apr 2021"},{"key":"3432_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27379","author":"A Mahmood","year":"2022","unstructured":"Mahmood A, Shujaat SA, Hayat M, Ijaz F, Habib S, Sadaqat W et al (2022) Acute adverse effects of vaccines against SARS-COV-2. Cureus. https:\/\/doi.org\/10.7759\/cureus.27379","journal-title":"Cureus"},{"issue":"10","key":"3432_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/vaccines10101765","volume":"10","author":"S Thonginnetra","year":"2022","unstructured":"Thonginnetra S, Tawinprai K, Niemsorn K, Promsena P, Tandhansakul M, Kasemlawan N et al (2022) Safety after BBIBP-CorV (Sinopharm) COVID-19 vaccine in adolescents aged 10\u201317 years in Thailand. Vaccines 10(10):1765. https:\/\/doi.org\/10.3390\/vaccines10101765","journal-title":"Vaccines"},{"key":"3432_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.834744","author":"MEC Moll","year":"2022","unstructured":"Moll MEC, Mart\u00ednez AMS, Cisneros BT, Onofre JIG, Floriano GN, de Le\u00f3n MB (2022) Extension and severity of self-reported side effects of seven COVID-19 vaccines in mexican population. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2022.834744","journal-title":"Front Public Health"},{"issue":"7","key":"3432_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P et al (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3432_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/vaccines10020186","volume":"10","author":"HM Attash","year":"2022","unstructured":"Attash HM, Al-Obaidy LM, Al-Qazaz HK (2022) Which type of the promising COVID-19 vaccines produces minimal adverse effects? A retrospective cross-sectional study. Vaccines 10(2):186. https:\/\/doi.org\/10.3390\/vaccines10020186","journal-title":"Vaccines"},{"issue":"8","key":"3432_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/head.14374","volume":"62","author":"R Magdy","year":"2022","unstructured":"Magdy R, Khedr D, Yacoub O, Attia A, Abdelrahman MA, Mekkawy D (2022) Epidemiological aspects of headache after different types of COVID-19 vaccines: an online survey. Headache: J Head Face Pain 62(8):1046\u20131052. https:\/\/doi.org\/10.1111\/head.14374","journal-title":"Headache: J Head Face Pain"},{"issue":"3","key":"3432_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/vaccines10030366","volume":"10","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM, Al-Hatamleh MA, Olaimat AN, Mohamud R, Fawaz M, Kateeb ET et al (2022) Reported adverse effects and attitudes among Arab populations following COVID-19 vaccination: a large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors. Vaccines 10(3):366. https:\/\/doi.org\/10.3390\/vaccines10030366","journal-title":"Vaccines"},{"issue":"6","key":"3432_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/vaccines9060556","volume":"9","author":"MM Hatmal","year":"2021","unstructured":"Hatmal MM, Al-Hatamleh MA, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM et al (2021) Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines 9(6):556. https:\/\/doi.org\/10.3390\/vaccines9060556","journal-title":"Vaccines"},{"issue":"2","key":"3432_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/vaccines10020292","volume":"10","author":"MS Boshra","year":"2022","unstructured":"Boshra MS, Hussein RR, Mohsen M, Elberry AA, Altyar AE, Tammam M et al (2022) A battle against COVID-19: vaccine hesitancy and awareness with a comparative study between Sinopharm and AstraZeneca. Vaccines 10(2):292. https:\/\/doi.org\/10.3390\/vaccines10020292","journal-title":"Vaccines"},{"issue":"6","key":"3432_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/vaccines9060577","volume":"9","author":"O Abu-Hammad","year":"2021","unstructured":"Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A et al (2021) Side effects reported by Jordanian healthcare workers who received COVID-19 vaccines. Vaccines 9(6):577. https:\/\/doi.org\/10.3390\/vaccines9060577","journal-title":"Vaccines"},{"issue":"1","key":"3432_CR25","first-page":"45","volume":"72","author":"R Al-Zidan","year":"2023","unstructured":"Al-Zidan R, Darweesh O, Salah M, Bebane P, Ahmed H, Abdulrazzaq G et al (2023) Are some COVID-19 vaccines better than others regarding the short-term side effects? Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 72(1):45\u201354","journal-title":"Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti"},{"key":"3432_CR26","unstructured":"Possible side effects after getting a COVID-19 vaccine (2021). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html. Accessed 29 Sept 2023"},{"issue":"12","key":"3432_CR27","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1002\/jmv.27214","volume":"93","author":"QA Al Khames Aga","year":"2021","unstructured":"Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT et al (2021) Safety of COVID-19 vaccines. J Med Virol 93(12):6588\u20136594. https:\/\/doi.org\/10.1002\/jmv.27214","journal-title":"J Med Virol"},{"key":"3432_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","volume":"111","author":"BQ Saeed","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO (2021) Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis 111:219\u2013226. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.013","journal-title":"Int J Infect Dis"},{"issue":"7","key":"3432_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/jcm10071428","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M (2021) Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med 10(7):1428. https:\/\/doi.org\/10.3390\/jcm10071428","journal-title":"J Clin Med"},{"issue":"5","key":"3432_CR30","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.dsx.2021.102207","volume":"15","author":"HB Almufty","year":"2021","unstructured":"Almufty HB, Mohammed SA, Abdullah AM, Merza MA (2021) Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr: Clin Res Rev 15(5):102207. https:\/\/doi.org\/10.1016\/j.dsx.2021.102207","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"issue":"12","key":"3432_CR31","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/jcm10122629","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Sa\u011f\u0131ro\u011flu D, \u00dcst\u00fcn B, Pokorn\u00e1 A, Klugarov\u00e1 J, Attia S et al (2021) Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in Turkey. J Clin Med 10(12):2629. https:\/\/doi.org\/10.3390\/jcm10122629","journal-title":"J Clin Med"},{"issue":"5","key":"3432_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10(5):338\u2013349. https:\/\/doi.org\/10.1016\/S1473-3099(10)70049-9","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3432_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00963-7","volume":"11","author":"F Babamahmoodi","year":"2021","unstructured":"Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G et al (2021) Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Sci Rep 11(1):1\u20138. https:\/\/doi.org\/10.1038\/s41598-021-00963-7","journal-title":"Sci Rep"},{"issue":"11","key":"3432_CR34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/vaccines9111321","volume":"9","author":"I Iguacel","year":"2021","unstructured":"Iguacel I, Maldonado AL, Ruiz-Cabello AL, Casaus M, Moreno LA, Mart\u00ednez-Jarreta B (2021) Association between COVID-19 vaccine side effects and body mass index in Spain. Vaccines 9(11):1321. https:\/\/doi.org\/10.3390\/vaccines9111321","journal-title":"Vaccines"},{"key":"3432_CR35","volume-title":"Sinopharm\/BBIBP COVID-19 vaccine","author":"Evidence Assessment","year":"2021","unstructured":"Evidence Assessment (2021) Sinopharm\/BBIBP COVID-19 vaccine. World Health Organization, Geneva"},{"key":"3432_CR36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27297","author":"FHI Amer","year":"2022","unstructured":"Amer FHI, Alzayyat R, Alzayyat N, Alomran S, Wafai S, Alabssi H et al (2022) Side effects of COVID-19 vaccines (Pfizer, AstraZeneca) in Saudi Arabia, Eastern Province. Cureus. https:\/\/doi.org\/10.7759\/cureus.27297","journal-title":"Cureus"},{"issue":"9","key":"3432_CR37","doi-asserted-by":"publisher","first-page":"738","DOI":"10.4239\/wjd.v13.i9.738","volume":"13","author":"G Vasilev","year":"2022","unstructured":"Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T (2022) Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 13(9):738\u2013751. https:\/\/doi.org\/10.4239\/wjd.v13.i9.738","journal-title":"World J Diabetes"},{"key":"3432_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940357","author":"AB Boroumand","year":"2022","unstructured":"Boroumand AB, Forouhi M, Karimi F, Soltani Moghadam A, Ghanbari Naeini L, Kokabian P et al (2022) Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: a systematic review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.940357","journal-title":"Front Immunol"},{"key":"3432_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2184754","author":"X Zhou","year":"2023","unstructured":"Zhou X, Lu H, Sang M, Qiu S, Yuan Y, Wu T et al (2023) Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes. Hum Vaccines Immunother. https:\/\/doi.org\/10.1080\/21645515.2023.2184754","journal-title":"Hum Vaccines Immunother"},{"issue":"11","key":"3432_CR40","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1128\/CVI.00288-15","volume":"22","author":"YB Seo","year":"2015","unstructured":"Seo YB, Baek JH, Lee J, Song JY, Lee JS, Cheong HJ et al (2015) Long-term immunogenicity and safety of a conventional influenza vaccine in patients with type 2 diabetes. Clin Vaccine Immunol 22(11):1160\u20131165. https:\/\/doi.org\/10.1128\/CVI.00288-15","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"3432_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/nep.13980","volume":"27","author":"SG Holt","year":"2022","unstructured":"Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I et al (2022) An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology 27(3):260\u2013268. https:\/\/doi.org\/10.1111\/nep.13980","journal-title":"Nephrology"},{"issue":"4","key":"3432_CR42","first-page":"259","volume":"16","author":"A Alirezaei","year":"2022","unstructured":"Alirezaei A, Fazeli SA, Shafiei M, Miladipour A (2022) Efficacy of Sinopharm\u00ae COVID-19 vaccine in hemodialysis patients: a preliminary report. Iran J Kidney Dis 16(4):259","journal-title":"Iran J Kidney Dis"},{"issue":"4","key":"3432_CR43","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/TP.0000000000003983","volume":"106","author":"J-SF Sanders","year":"2022","unstructured":"Sanders J-SF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R et al (2022) The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant. Transplantation 106(4):821\u2013834. https:\/\/doi.org\/10.1097\/TP.0000000000003983","journal-title":"Transplantation"},{"issue":"9","key":"3432_CR44","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/ndt\/gfab179","volume":"36","author":"B Simon","year":"2021","unstructured":"Simon B, Rubey H, Treipl A, Gromann M, Hemedi B, Zehetmayer S et al (2021) Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls. Nephrol Dial Transpl 36(9):1709\u20131716. https:\/\/doi.org\/10.1093\/ndt\/gfab179","journal-title":"Nephrol Dial Transpl"},{"key":"3432_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00617-5","author":"N Babel","year":"2022","unstructured":"Babel N, Hugo C, Westhoff TH (2022) Vaccination in patients with kidney failure: lessons from COVID-19. Nat Rev Nephrol. https:\/\/doi.org\/10.1038\/s41581-022-00617-5","journal-title":"Nat Rev Nephrol"},{"issue":"61","key":"3432_CR46","doi-asserted-by":"publisher","first-page":"eabj1031","DOI":"10.1126\/sciimmunol.abj1031","volume":"6","author":"H Rincon-Arevalo","year":"2021","unstructured":"Rincon-Arevalo H, Choi M, Stefanski A-L, Halleck F, Weber U, Szelinski F et al (2021) Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol 6(61):eabj1031. https:\/\/doi.org\/10.1126\/sciimmunol.abj1031","journal-title":"Sci Immunol"},{"issue":"Supplement 2","key":"3432_CR47","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1513\/AnnalsATS.201503-126AW","volume":"12","author":"TA Bhat","year":"2015","unstructured":"Bhat TA, Panzica L, Kalathil SG, Thanavala Y (2015) Immune dysfunction in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 12(Supplement 2):S169\u2013S175. https:\/\/doi.org\/10.1513\/AnnalsATS.201503-126AW","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"3432_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1164\/rccm.201312-2293OC","volume":"190","author":"SG Kalathil","year":"2014","unstructured":"Kalathil SG, Lugade AA, Pradhan V, Miller A, Parameswaran GI, Sethi S et al (2014) T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190(1):40\u201350. https:\/\/doi.org\/10.1164\/rccm.201312-2293OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3432_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R (2020) Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 16(5):442. https:\/\/doi.org\/10.2174\/1573399815666191024085838","journal-title":"Curr Diabetes Rev"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:04:54Z","timestamp":1700244294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03432-8","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients signed informed consent before any study-related procedures were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The patients were informed of the purpose of this study and an informed written consent has been obtained from the patients to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This study was approved by the approved by the Ethics Committee of Ardabil University of Medical Sciences, Ardabil, Iran (IR.ARUMS.REC.1400.212).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"377"}}